TREPROSTINIL
Drug
Sandoz Inc.
Total Payments
$25,855
Transactions
880
Doctors
513
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3,638 | 136 | 117 |
| 2023 | $7,584 | 238 | 178 |
| 2022 | $3,665 | 140 | 113 |
| 2021 | $1,699 | 64 | 57 |
| 2020 | $842.03 | 41 | 38 |
| 2019 | $8,050 | 243 | 153 |
| 2018 | $377.12 | 18 | 18 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,355 | 878 | 90.3% |
| Space rental or facility fees (teaching hospital only) | $2,500 | 2 | 9.7% |
Top Doctors Receiving Payments for TREPROSTINIL — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , N.P | Acute Care | Dallas, TX | $166.61 | 2 |
| , M.D., | Pulmonary Disease | New York, NY | $165.32 | 2 |
| , DO | Critical Care Medicine | Euclid, OH | $153.82 | 7 |
| , M.D | Cardiovascular Disease | Cincinnati, OH | $153.06 | 2 |
| , M.D | Internal Medicine | Milwaukee, WI | $147.84 | 2 |
| , M.D | Critical Care Medicine | Mobile, AL | $146.92 | 8 |
| , MD | Student in an Organized Health Care Education/Training Program | Houston, TX | $146.48 | 7 |
| , M.D | Cardiovascular Disease | Columbus, GA | $145.55 | 2 |
| , M.D | Advanced Heart Failure and Transplant Cardiology | Asheville, NC | $143.78 | 2 |
| , MD | Pulmonary Disease | Phoenix, AZ | $138.42 | 6 |
| , MD | Pulmonary Disease | Phoenix, AZ | $137.21 | 6 |
| Arun Jose | Internal Medicine | Cincinnati, OH | $127.10 | 3 |
| , FNP-C | Specialist | Houston, TX | $126.37 | 8 |
| , M.D | Critical Care Medicine | Columbus, OH | $123.61 | 4 |
| , NP | Acute Care | Houston, TX | $122.63 | 6 |
| , APRN | Nurse Practitioner | Louisville, KY | $119.81 | 1 |
| , M.D | Critical Care Medicine | Louisville, KY | $119.81 | 1 |
| , PA-C | Physician Assistant | Salt Lake City, UT | $118.81 | 2 |
| , D.N.P | Family | Salt Lake City, UT | $118.81 | 2 |
| , ACNP-BC | Acute Care | Pasadena, TX | $118.51 | 7 |
| , M.D | Pulmonary Disease | Beachwood, OH | $116.76 | 6 |
| , M.D | Internal Medicine | Boston, MA | $110.05 | 3 |
| , M.D | Advanced Heart Failure and Transplant Cardiology | Baltimore, MD | $107.95 | 4 |
| , MD | Pulmonary Disease | Mobile, AL | $103.88 | 6 |
| , MS, RN, AGNP-C | Registered Nurse | Plano, TX | $99.37 | 4 |
Ad
Manufacturing Companies
- Sandoz Inc. $25,855
Product Information
- Type Drug
- Total Payments $25,855
- Total Doctors 513
- Transactions 880
About TREPROSTINIL
TREPROSTINIL is a drug associated with $25,855 in payments to 513 healthcare providers, recorded across 880 transactions in the CMS Open Payments database. The primary manufacturer is Sandoz Inc..
Payment data is available from 2018 to 2024. In 2024, $3,638 was paid across 136 transactions to 117 doctors.
The most common payment nature for TREPROSTINIL is "Food and Beverage" ($23,355, 90.3% of total).